City

Jacksonville (1)

New York (1)

Rochester (1)

Scottsdale (1)

Condition

Metastatic Salivary Gland Carcinoma (2)

Recurrent Salivary Gland Carcinoma (2)

Stage IV Major Salivary Gland Cancer AJCC v8 (2)

Stage III Major Salivary Gland Cancer AJCC v8 (1)

Stage IVA Major Salivary Gland Cancer AJCC v8 (1)

Stage IVB Major Salivary Gland Cancer AJCC v8 (1)

Stage IVC Major Salivary Gland Cancer AJCC v8 (1)

Unresectable Salivary Gland Carcinoma (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

Mayo Clinic (1)

NRG Oncology (1)

Collaborator

National Cancer Institute (NCI) (2)

Intervention

docetaxel (1)

pembrolizumab (1)

pemetrexed disodium (1)

questionnaire administration (1)

trastuzumab (1)

trastuzumab emtansine (1)

Study Documents

Intervention Type

biological (2)

drug (2)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

stage iv major salivary gland cancer ajcc v8

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

Recruiting

Metastatic Salivary Gland Carcinoma
+4 more

Docetaxel
+3 more

New York, New York

Memorial Sloane Kettering Cancer Center

Jan 11, 2023

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8 Trial in

Recruiting

Metastatic Salivary Gland Carcinoma
+5 more

Pembrolizumab
Pemetrexed Disodium

Scottsdale, Arizona
+2 more

Mar 15, 2022